Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment
Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat Dravet ...
CHAP: COMMUNITY HEALTH ACCREDITATION PARTNER AWARDS MAXWELL HEALTHCARE ASSOCIATES' nanaBEREAVEMENT PRODUCT ITS "CHAP VERIFIED" STATUS
Maxwell Healthcare Associates (MHA) is pleased to announce that nanaBEREAVEMENT, a tech-enabled bereavement support solution, was awarded the "CHAP Verified" seal by the Community Health Accreditation ...